FFA
ALXN

Freedman Financial Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Freedman Financial Associates’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-207
Closed -$38K – 546
2021
Q2 		$38K Hold
207
– – 0.03% 224
2021
Q1 		$32K Hold
207
– – 0.03% 253
2020
Q4 		$32K Buy
+207
New +$32K 0.03% 242